carbromal
{{cs1 config|name-list-style=vanc}}
{{chembox
| ImageFile = Carbromal.svg
| ImageFile_Ref = {{chemboximage|correct|??}}
| ImageName = Skeletal formula of carbromal
| IUPACName = 2-Bromo-N-carbamoyl-2-ethylbutanamide
|Section1={{Chembox Identifiers
| CASNo = 77-65-6
| CASNo_Ref = {{cascite|correct|??}}
| PubChem = 6488
| ChemSpiderID = 6243
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| UNII = 0Y299JY9V3
| UNII_Ref = {{fdacite|correct|FDA}}
| EINECS = 201-046-6
| KEGG = D02619
| KEGG_Ref = {{keggcite|correct|kegg}}
| MeSHName = carbromal
| ChEMBL = 1697828
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| SMILES = CCC(Br)(CC)C(=O)NC(N)=O
| StdInChI = 1S/C7H13BrN2O2/c1-3-7(8,4-2)5(11)10-6(9)12/h3-4H2,1-2H3,(H3,9,10,11,12)
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = OPNPQXLQERQBBV-UHFFFAOYSA-N
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
}}
|Section2={{Chembox Properties
| C=7 | H=13 | Br=1 | N=2 | O=2
| Appearance = White crystals
| Odor = Odorless
| Density = 1.544 g/cm3
| MeltingPtC = 119
| Solubility = Soluble
| SolubleOther = soluble in chloroform, ether, acetone, benzene
| LogP = 1.623
| pKa = 10.69
| pKb = 3.31
}}
|Section5={{Chembox Structure
| CrystalStruct = rhombic
}}
|Section6={{Chembox Pharmacology
| ATCCode_prefix = N05
| ATCCode_suffix = CM04
}}
|Section8={{Chembox Related
| OtherFunction_label = ureas
| OtherFunction = Bromisoval
| OtherCompounds = {{unbulleted list|3-Ureidopropionic acid|beta-Ureidoisobutyric acid|Carbamoyl aspartic acid|N-Acetylaspartic acid|Aceglutamide|N-Acetylglutamic acid|Citrulline}}
}}
}}
Carbromal is a hypnotic/sedative originally synthesized in 1909 by Bayer and subsequently marketed as Adalin.{{cite journal | vauthors = Borrie P | title = A purpuric drug eruption caused by carbromal | journal = British Medical Journal | volume = 1 | issue = 4914 | pages = 645–6 | date = March 1955 | pmid = 13230580 | pmc = 2061381 | doi = 10.1136/bmj.1.4914.645 }}{{cite patent|country=DE|number=22571|pubdate=1910-09-17|title=Verfahren dur Darstellung von Bromodiäthylacetylharnstoff [Method for the preparation of bromodiethylacetylurea]|assign=Friedrich Bayer & Co.}} The drug was later sold by Parke-Davis in combination with pentobarbital, under the name Carbrital.{{Cite book|url=https://www.worldcat.org/oclc/4636066|title=Physicians' Desk Reference.|date=1979|publisher=Medical Economics Co|isbn=0-87489-999-0|edition=33|location=Oradell, N.J.|pages=1266|oclc=4636066}} As of 2015, it was still used in Hungary in combination with aminophenazone under the name Demalgon.
Synthesis
Diethylmalonic acid [510-20-3] (1) is decarboxylated to 2-ethylvaleric acid [20225-24-5] (2). The Hell-Volhard-Zelinsky reaction converts this to 2-Bromo-2-Ethylbutyryl Bromide [26074-53-3] (3). Reaction with urea with affords carbromal (4).
See also
References
{{Reflist|2}}
{{Hypnotics}}
{{GABAAergics}}
Category:GABAA receptor positive allosteric modulators
Category:Drugs developed by Bayer
{{sedative-stub}}